Patent details
LUC00285
Product Name:
Onasemnogene abeparvovec
Basic Information
- Publication number:
- LUC00285
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
-
EP191581529
- Legal Status:
- Inactive
- Application number:
- LUC00285
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/20/1443
- Marketing Authorization Type:
-
- Marketing Authorization Date:
- 18/05/2020
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 17/11/2022
- First Marketing Authorization date:
- 18/05/2020
- Grant date:
- 12/05/2025
- Activation date:
- Publication date:
- 23/11/2022
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 03/10/2033
- SPC Extension Expiration:
- 03/10/2033
- Rejection date:
- Withdrawal date:
Owner
- From:
- 17/11/2022
-
-
- Name:
- CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
- Address:
- 3, rue Michel Ange, 75016 Paris, France (FR)
- Name:
- Genethon
- Address:
- 1 bis rue de l'Internationale, 91000 Evry, France (FR)
Agent
- Name:
- MARKS & CLERK LLP
- From:
- 17/11/2022
- Address:
- BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2022/13
- Publication date:
- 01/12/2022
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
2
- Bulletin Heading:
- SPC2
- Bulletin edition number:
- 2025/07
- Publication date:
- 04/06/2025
- Description:
- Section D : Granted supplementary protection certificates – I2 publication
Annual Fees
- Annual Fee Due Date:
- 31/10/2028
- Annual Fee Number:
- 21
- Annual Fee Amount:
- 410 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-